Stockscreener 앱 받기
10.56
0.19%
-0.02
전일 마감가:
$10.58
열려 있는:
$11
하루 거래량:
12,462
Relative Volume:
0.68
시가총액:
$232.95M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.52%
1개월 성능:
+2.03%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$10.45
$11.00
1주일 범위
$10.20
$11.00
52주 변동 폭
$10.11
$11.00
Helix Acquisition Corp Iii Stock (HLXC) Company Profile
명칭
Helix Acquisition Corp Iii
전화
(857) 702-0370
주소
C/O CORMORANT ASSET MANAGEMENT LP, BOSTON
Compare HLXC vs LION, XXI, UMAC, CCXI, DMII
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HLXC
Helix Acquisition Corp Iii
|
10.56 | 232.95M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
13.59 | 3.98B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
4.8895 | 1.85B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
17.88 | 830.66M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
14.55 | 801.52M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.09 | 642.73M | 0 | 8.58M | -1.11M | 0.134 |
Helix Acquisition Corp Iii 주식(HLXC)의 최신 뉴스
TRADING UPDATES: MedPal acquisition; Helix begins helium sales - London South East
Helix Acquisition Corp. III (HLXC) Faces Selling Pressure, Key Levels in FocusBullish Percent Index - dars.gov.et
Helix acquires $11m helium liquefaction plant in Oklahoma - t.co
If You Invested $1,000 in Helix Acqsn II (HLXB) - Stock Titan
Helix Acquisition Corp. III (HLXC) Holds Steady at $10.60 Amid Minimal MovementFear Greed Extreme - DonanımHaber
Price to earnings forward of Helix Acquisition Corp. III – NASDAQ:HLXC - TradingView
Cormorant funds tied to BBOT (NASDAQ: BBOT) receive 4.53M shares in internal distribution - Stock Titan
Price to book forward of Helix Acquisition Corp. III – NASDAQ:HLXC - TradingView
HLXCHelix Acquisition Corp III Latest SEC Filings - Finviz
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Staggering EPS Miss Amid Limited Revenue VisibilityFinancial Data - dars.gov.et
Helix Acquisition Corp II (HLXB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MoonLake Immunotherapeutics (NASDAQ: MLTX) offers 9M shares at $20; 1M pre-funded warrants - Stock Titan
MoonLake Immunotherapeutics (NASDAQ: MLTX) seeks $150M via offering - Stock Titan
SpaceX and SanDisk among market cap stock movers on Monday By Investing.com - Investing.com South Africa
SpaceX and SanDisk among market cap stock movers on Monday - Investing.com UK
Helix Acquisition Corp II (HLXB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Helix Acquisition Corp II (HLXB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Helix Acquisition Corp II (HLXB) Institutional Confidence - TradingKey
Helix Acquisition Corp II (HLXB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Helix Acquisition Corp II (HLXB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Helix Acquisition Corp II (HLXB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Helix Acquisition Corp II (HLXB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Helix Acquisition Corp II (HLXB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GRO Relocates to Doha After Securing Qatari GrowthX Capital InvestmentReturn On Equity - newsline.com
Berkshire Hathaway Viewed as AI-Resilient by Greenskeeper Asset ManagementSubscription Growth Report - newsline.com
SpaceX Joins Nasdaq After Record-Breaking Public OfferingEPS Growth Report - newsline.com
JNJ Q1 2026 Earnings: Adjusted EPS Slightly Beats Estimates, Stock RisesEarnings Beat Streak - newsline.com
Molina Healthcare (MOH): Examining Its Position in the Healthcare SectorEarnings Expansion Phase - newsline.com
Summit Midstream Corporation (SMC) Holds Near Resistance as Energy Sector Shows Cautious OptimismGap Up Stocks - newsline.com
NBIS Q1 2026 Earnings: EPS Surprise Beats Estimates by 59% Despite Negative EarningsHealthcare Earnings Report - newsline.com
Helix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026 - Yahoo Finance
TRADING UPDATES: Unicorn Mineral; Helix Exploration agree acquisitions - London South East
Anthropic Warns AI Could Develop Without Human Oversight, Calls for Regulatory SafeguardsROE Trend Analysis - newsline.com
Karen Bass and Spencer Pratt May Face Runoff in Los Angeles Mayoral RaceOne-Time Gain Impact - newsline.com
FTRA.U Stock Fund Price and Chart — NYSE:FTRA.U - TradingView
Helix BioPharma Corp. Announces Closing of Private Placement of Convertible Debentures - Yahoo Finance
MoonLake Immunotherapeutics Signs Manufacturing Agreement with Vetter Pharma – SEC 8-K Filing Details 8 - Minichart
EQIX Q1 2026 Earnings: EPS Slightly Misses Estimates; Stock Edges LowerDividend Earnings Report - The Legal Advocate
Helix Acquisition Corp. III (HLXC) Holds Steady Near $10.21 Amid SPAC SpeculationTriple MA Cross - DonanımHaber
LIEN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
EverQuote (EVER) Q1 2026 Earnings: EPS Surges Past Estimates with 14% BeatQuarterly Earnings - newsline.com
Helix Acquisition Corp. III (HLXC) Holds Steady at $10.22, Signaling Stability in SPAC TerritoryOBV Breakout - The Legal Advocate
AACP Stock Price and Chart — NASDAQ:AACP - TradingView
India’s Engineering Goods Exports Rise 8.8% in April Despite Decline in UAE, Saudi Arabia ShipmentsEPS Growth Rate - The Legal Advocate
Helix Acquisition Corp. III (HLXC) Holds Steady Near Trust Value Amid Minimal MovementWeekly Profile - The Legal Advocate
BBOTBridgeBio Oncology Therapeutics Inc Stock Price and Quote - Finviz
Cuprina Holdings (CUPR) Slides 9%: Key Support Levels Under PressureVolume Nodes - The Legal Advocate
HTCR Q2 2025 Earnings: Stunning EPS Beat Drives Double-Digit Stock SurgeBook Value Growth - newsline.com
AI Adoption Faces Cost Hurdle: Reports Suggest Technology May Be More Expensive Than Human LaborEBITDA Analysis - newsline.com
RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING - Yahoo Finance
BlossomHill Therapeutics Expands Board of Directors with the Appointments of Sheila Gujrathi, M.D., and John Schmid - The Manila Times
Helix Acquisition Corp Iii (HLXC) 재무 분석
Helix Acquisition Corp Iii (HLXC)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.43%
0.10%
자본화:
|
볼륨(24시간):